Advisor

Sanofi’s Strategy for Practical, Scalable & Sustainable Data Analytics

Posted February 5, 2025 | Technology |
Sanofi’s Strategy for Practical, Scalable & Sustainable Data Analytics

In a previous Advisor, we outlined our rationale behind transitioning from reactive modes of data analytics (namely descriptive and diagnostic analytics) to a proactive approach through prescriptive analytics. This Advisor reflects on the vision and strategy that drove the journey.

Vision & Strategy

Our prescriptive analytics implementation was rooted in our vision to improve operational efficiency and product quality by shifting from reactive to proactive modes of operation. In short, we conceptualized a pragmatic digital capability that could be integrated with a new way of working to proactively identify and expediently resolve process-related challenges.

This vision translated into a primary objective: empowering stakeholders with rapid and live data analytics capabilities, enabling swift monitoring of the latest batches, and providing process-related suggestions to mitigate or avoid unfavorable process-performance situations. We aimed to detect anomalies and divergence in process performance while providing actionable recommendations to mitigate potential issues. To reach this objective, we formulated a strategy that prioritized practicality, scalability, and sustainability in product design and deployment (see Figure 1).

 

Figure 2. Designing and deploying the prescriptive analytics tool
Figure 1. Designing and deploying the prescriptive analytics tool

 

In designing the product, we took a practical, realistic approach that addressed the specific needs and limitations of our business environment. Numerous ideas were proposed, but we recognized the importance of simplicity and effectiveness in ensuring user adoption and decision-making support. We therefore focused on providing actionable information without requiring users to run models or manipulate data sets. This streamlined approach ensured that the tool remained user-friendly and streamlined decision-making.

Our strategy also placed a significant emphasis on scalability, striving to craft a general framework that could be adapted to various process areas with minimal effort. Embracing a product-agnostic approach facilitated rapid deployment, enabling seamless integration into new areas in a matter of days. By formulating a business knowledge and parameter-mapping database to collect product- and process-specific requirements for each area and generating generalized code for visualizations and insights, we laid the groundwork for a scalable solution capable of evolving alongside our expanding facilities and products.

To ensure sustainability, we paid close attention to managing the execution, maintenance, and updates of the product within existing resource constraints. Effectively balancing the workload of the new product with ongoing tasks, projects, and manufacturing support ensured its viability and efficacy. Our aim was not to add to the workload of our teams, but rather to streamline their processes and provide them with the tools necessary to make informed decisions.

[For more from the authors on this topic, see: “Vision into Action: A Reflection on Sanofi’s Prescriptive Analytics Journey.”]

About The Author
Hossein Sahraei
Hossein Sahraei is Deputy Director of Process Analytics, MSAT Data Science, at Sanofi, where he leads the implementation of automated prescriptive analytics for proactive yield management across diverse vaccine manufacturing processes. With over 10 years’ experience in data analytics, Dr. Sahraei specializes in translating strategic objectives into actionable plans through data-driven solutions. He also leads technical teams, ensuring efficient… Read More
Ramila Peiris
Ramila Peiris is Head of Data Science at Sanofi, where he provides strategy and vision for data engineering, advanced modeling, and AI solutions. Dr. Peiris has an extensive background in the development and application of data science solutions and has spent over 15 years working in the pharmaceutical, water, and specialty chemicals industries. He is driven by the impact of his work, delivering practical and game-changing solutions, and… Read More
Luc Nguyen
Luc Nguyen is Head of MSAT for the Toronto Vaccine site at Sanofi. He has over 25 years’ experience in the pharmaceutical manufacturing space, including vaccines, injectables, oral liquid, and R&D. Mr. Nguyen has managed cross-functional teams in manufacturing, R&D, quality, and commercial operations. He is a strong believer in using data and advanced analytics to enable business operations in achieving compliance, productivity, and… Read More
Olivier Moureau
Olivier Moureau is Head of Process Data Science and Digital Transformation, Global MSAT, at Sanofi, where he leads dynamic teams focused on leveraging data and AI for process development, optimization, monitoring, and digital transformation across Sanofi‘s entire manufacturing and supply portfolio. With a background in engineering and statistics, he brings over 18 years’ experience in data science to his role. Previously, Mr. Moureau held… Read More